{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:12:49Z","timestamp":1774620769934,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12519-020-00359-z","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T16:04:34Z","timestamp":1589213074000},"page":"446-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Acute infectious osteomyelitis in children: new treatment strategies for an old enemy"],"prefix":"10.1007","volume":"16","author":[{"given":"Sabrina","family":"Congedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Minotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Giaquinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liviana","family":"Da Dalt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Don\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"359_CR1","first-page":"e204","volume":"45","author":"NSB Whyte","year":"2016","unstructured":"Whyte NSB, Bielski RJ. Acute hematogenous osteomyelitis in children. Pediatr Ann. 2016;45:e204\u20138.","journal-title":"Pediatr Ann."},{"key":"359_CR2","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1097\/BPO.0000000000001152","volume":"38","author":"WT Davis","year":"2018","unstructured":"Davis WT, Gilbert SR. Comparison of methicillin-resistant versus susceptible staphylococcus aureus pediatric osteomyelitis. J Pediatr Orthop. 2018;38:e285\u201391.","journal-title":"J Pediatr Orthop."},{"key":"359_CR3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpeds.2018.12.002","volume":"208","author":"RF Hamdy","year":"2019","unstructured":"Hamdy RF, Dona D, Jacobs MB, Gerber JS. Risk factors for complications in children with Staphylococcus aureus bacteremia. J Pediatr. 2019;208:214\u2013220.e2.","journal-title":"J Pediatr."},{"key":"359_CR4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.idc.2015.05.012","volume":"29","author":"JC Arnold","year":"2015","unstructured":"Arnold JC, Bradley JS. Osteoarticular infections in children. Infect Dis Clin North Am. 2015;29:557\u201374.","journal-title":"Infect Dis Clin North Am."},{"key":"359_CR5","doi-asserted-by":"crossref","first-page":"g66","DOI":"10.1136\/bmj.g66","volume":"348","author":"A Yeo","year":"2014","unstructured":"Yeo A, Ramachandran M. Acute haematogenous osteomyelitis in children. BMJ. 2014;348:g66.","journal-title":"BMJ"},{"key":"359_CR6","first-page":"1365","volume":"370","author":"M Paakkonen","year":"2014","unstructured":"Paakkonen M, Peltola H. Acute osteomyelitis in children. N Engl J Med. 2014;370:1365\u20136.","journal-title":"N Engl J Med."},{"key":"359_CR7","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/jpc.12251","volume":"49","author":"AR Howard-Jones","year":"2013","unstructured":"Howard-Jones AR, Isaacs D. Systematic review of duration and choice of systemic antibiotic therapy for acute haematogenous bacterial osteomyelitis in children. J Paediatr Child Health. 2013;49:760\u20138.","journal-title":"J Paediatr Child Health."},{"key":"359_CR8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1302\/0301-620X.94B5.28523","volume":"94B","author":"J Dartnell","year":"2012","unstructured":"Dartnell J, Ramachandran M, Katchburian M. Haematogenous acute and subacute paediatric osteomyelitis. J Bone Jt Surg Br. 2012;94B:584\u201395.","journal-title":"J Bone Jt Surg Br."},{"key":"359_CR9","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/PEC.0000000000002045","volume":"36","author":"E Boccuzzi","year":"2020","unstructured":"Boccuzzi E, Buonsenso D, Ferro V, Raucci U, Reale A, Piga S, et al. The osteoarticular infection in a pediatric emergencysetting: a challenging diagnosis. Pediatr Emerg Care. 2020;36:e108\u201314.","journal-title":"Pediatr Emerg Care."},{"key":"359_CR10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5409\/wjcp.v5.i3.244","volume":"5","author":"N Batchelder","year":"2016","unstructured":"Batchelder N, So TY. Transitioning antimicrobials from intravenous to oral in pediatric acute uncomplicated osteomyelitis. World J Clin Pediatr. 2016;5:244\u201350.","journal-title":"World J Clin Pediatr."},{"key":"359_CR11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11908-011-0202-z","volume":"13","author":"I Thomsen","year":"2011","unstructured":"Thomsen I, Creech CB. Advances in the diagnosis and management of pediatric osteomyelitis. Curr Infect Dis Rep. 2011;13:451\u201360.","journal-title":"Curr Infect Dis Rep."},{"key":"359_CR12","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2106\/JBJS.J.01154","volume":"93","author":"KL Ju","year":"2011","unstructured":"Ju KL, Zurakowski D, Kocher MS. Differentiating between methicillin-resistant and methicillin-sensitive Staphylococcus aureus osteomyelitis in children: an evidence-based clinical prediction algorithm. J Bone Jt Surg Am. 2011;93:1693\u2013701.","journal-title":"J Bone Jt Surg Am."},{"key":"359_CR13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11999-009-0936-1","volume":"468","author":"M Paakkonen","year":"2010","unstructured":"Paakkonen M, Kallio MJT, Kallio PE, Peltola H. Sensitivity of erythrocyte sedimentation rate and C-reactive protein in childhood bone and joint infections. Clin Orthop Relat Res. 2010;468:861\u20136.","journal-title":"Clin Orthop Relat Res"},{"key":"359_CR14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1148\/radiol.2017151929","volume":"283","author":"D Jaramillo","year":"2017","unstructured":"Jaramillo D, Dormans JP, Delgado J, Laor T, St Geme JW. Hematogenous osteomyelitis in Infants and children: imaging of a changing disease. Radiology. 2017;283:629\u201343.","journal-title":"Radiology"},{"key":"359_CR15","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1097\/INF.0000000000000597","volume":"34","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Della Beffa C, Akmatov MK, Narchi H, Abaev YK, Sherry DD, et al. Primary osteomyelitis of the sternum in the pediatric age group: report of a new case and comprehensive analysis of seventy-four cases. Pediatr Infect Dis J. 2015;34:e92\u2013101.","journal-title":"Pediatr Infect Dis J."},{"key":"359_CR16","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00330-006-0187-4","volume":"16","author":"JM Mellado Santos","year":"2006","unstructured":"Mellado Santos JM. Diagnostic imaging of pediatric hematogenous osteomyelitis: lessons learned from a multi-modality approach. Eur Radiol. 2006;16:2109\u201319.","journal-title":"Eur Radiol"},{"key":"359_CR17","first-page":"150","volume":"18","author":"J Colston","year":"2018","unstructured":"Colston J, Atkins B. Bone and joint infection. Clin Med J R Coll Physicians Lond. 2018;18:150\u20134.","journal-title":"Clin Med J R Coll Physicians Lond."},{"key":"359_CR18","doi-asserted-by":"crossref","first-page":"e821","DOI":"10.1542\/peds.2012-0220","volume":"130","author":"JC Arnold","year":"2012","unstructured":"Arnold JC, Cannavino CR, Ross MK, Westley B, Miller TC, Riffenburgh RH, et al. Acute bacterial osteoarticular infections: eight-year analysis of C-reactive protein for oral step-down therapy. Pediatrics. 2012;130:e821\u20138.","journal-title":"Pediatrics"},{"key":"359_CR19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/BPO.0000000000000237","volume":"35","author":"NI Montgomery","year":"2015","unstructured":"Montgomery NI, Rosenfeld S. Pediatric osteoarticular infection update. J Pediatr Orthop. 2015;35:74\u201381.","journal-title":"J Pediatr Orthop."},{"key":"359_CR20","doi-asserted-by":"crossref","first-page":"e17185","DOI":"10.1097\/MD.0000000000017185","volume":"98","author":"P-A Hoppe","year":"2019","unstructured":"Hoppe P-A, Holzhauer S, Lala B, B\u00fchrer C, Gratopp A, Hanitsch LG, et al. Severe infections of Panton-Valentine leukocidin positive Staphylococcus aureus in children. Med (Baltim). 2019;98:e17185.","journal-title":"Med (Baltim)."},{"key":"359_CR21","doi-asserted-by":"crossref","first-page":"e16015","DOI":"10.1097\/MD.0000000000016015","volume":"98","author":"C Hardy","year":"2019","unstructured":"Hardy C, Osei L, Basset T, Elenga N. Bone and joint infections with Staphylococcus aureus strains producing Panton\u2013Valentine leukocidin in French Guiana. Med (Baltim). 2019;98:e16015.","journal-title":"Med (Baltim)."},{"key":"359_CR22","first-page":"301","volume":"17","author":"R Sankar","year":"2015","unstructured":"Sankar R. Bone and joint infections in children. Indian J Pract Pediatr. 2015;17:301\u20137.","journal-title":"Indian J Pract Pediatr."},{"key":"359_CR23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.2010-1867","volume":"127","author":"P Yagupsky","year":"2011","unstructured":"Yagupsky P, Porsch E, 3rd St Geme JW. Kingella kingae: an emerging pathogen in young children. Pediatrics. 2011;127:557\u201365.","journal-title":"Pediatrics"},{"key":"359_CR24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/INF.0b013e31816fc34c","volume":"27","author":"P Saphyakhajon","year":"2008","unstructured":"Saphyakhajon P. Empiric antibiotic therapy for acute osteoarticular infections with suspected methicillin-resistant staphylococcus aureus or kingella. Pediatr Infect Dis J. 2008;27:765\u20137.","journal-title":"Pediatr Infect Dis J."},{"key":"359_CR25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/01241398-200009000-00025","volume":"20","author":"JB Chambers","year":"2000","unstructured":"Chambers JB, Forsythe DA, Bertrand SL, Iwinski HJ, Steflik DE. Retrospective review of osteoarticular infections in a pediatric sickle cell age group. J Pediatr Orthop. 2000;20:682\u20135.","journal-title":"J Pediatr Orthop."},{"key":"359_CR26","first-page":"895","volume":"72","author":"LJ Miller","year":"2012","unstructured":"Miller LJ, Meier Riehm E. Sickle cell disease in children. Drugs. 2012;72:895\u2013906.","journal-title":"Drugs."},{"key":"359_CR27","first-page":"225","volume":"13","author":"FC Piehl","year":"1993","unstructured":"Piehl FC, Davis RJ, Prugh SI. Osteomyelitis in sickle cell disease. J Pediatr Orthop. 1993;13:225\u20137.","journal-title":"J Pediatr Orthop."},{"key":"359_CR28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5435\/00124635-200105000-00003","volume":"9","author":"KM Song","year":"2001","unstructured":"Song KM, Sloboda JF. Acute hematogenous osteomyelitis in children. J Am Acad Orthop Surg. 2001;9:166\u201375.","journal-title":"J Am Acad Orthop Surg."},{"key":"359_CR29","first-page":"1679306","volume":"8","author":"D Don\u00e0","year":"2018","unstructured":"Don\u00e0 D, Fovino LN, Mozzo E, Cabrelle G, Bordin G, Lundin R, et al. Case report osteomyelitis in cat-scratch disease : a never-ending dilemma \u2014 a case report and literature review. Case Rep Pediatr. 2018;8:1679306.","journal-title":"Case Rep Pediatr."},{"key":"359_CR30","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/INF.0b013e3181f55a89","volume":"29","author":"H Peltola","year":"2010","unstructured":"Peltola H, Paakkonen M, Kallio P, Kallio MJT, TO-SASG. Short-versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood. Pediatr Infect Dis J. 2010;29:1123\u20138.","journal-title":"Pediatr Infect Dis J."},{"key":"359_CR31","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1469-0691.2011.03643.x","volume":"18","author":"H Peltola","year":"2012","unstructured":"Peltola H, Paakkonen M, Kallio P, Kallio MJT, The OM-SA Study Group. Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood-a prospective quasi-randomized controlled trial. Clin Microbiol Infect. 2012;18:582\u20139.","journal-title":"Clin Microbiol Infect."},{"key":"359_CR32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-3476(78)80095-X","volume":"92","author":"TR Tetzlaff","year":"1978","unstructured":"Tetzlaff TR, Howard JB, McCraken GH, Calderon E, Larrondo J. Antibiotic concentrations in pus and bone of children with osteomyelitis. J Pediatr. 1978;92:135\u201340.","journal-title":"J Pediatr."},{"key":"359_CR33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/BPO.0b013e3181ab472d","volume":"29","author":"NA Jagodzinski","year":"2009","unstructured":"Jagodzinski NA, Kanwar R, Graham K, Ed F, Bache CE, Tr F. Prospective evaluation of a shortened regimen of treatment for acute osteomyelitis and septic arthritis in children. J Pediatr Orthop. 2009;29:518\u201325.","journal-title":"J Pediatr Orthop."},{"key":"359_CR34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-3476(78)80455-7","volume":"92","author":"TR Tetzlaff","year":"1978","unstructured":"Tetzlaff TR, McCracken GHJ, Nelson JD. Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis. J Pediatr. 1978;92:485\u201390.","journal-title":"J Pediatr."},{"key":"359_CR35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","volume":"48","author":"CB Landersdorfer","year":"2009","unstructured":"Landersdorfer CB, Bulitta JB, Kinzig M, Holzgrabe U, Sorgel F. Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations. Clin Pharmacokinet. 2009;48:89\u2013124.","journal-title":"Clin Pharmacokinet."},{"key":"359_CR36","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/BPO\/0b013e3181558981","volume":"27","author":"B Afghani","year":"2007","unstructured":"Afghani B, Kong V, Wu FL. What would pediatric infectious disease consultants recommend for management of culture-negative acute osteomyelitis? J Pediatr Orthop. 2007;27:805\u20139.","journal-title":"J Pediatr Orthop."},{"key":"359_CR37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/AAC.13.3.405","volume":"13","author":"RJ Fass","year":"1978","unstructured":"Fass RJ. Treatment of osteomyelitis and septic arthritis with cefazolin. Antimicrob Agents Chemother. 1978;13:405\u201311.","journal-title":"Antimicrob Agents Chemother."},{"key":"359_CR38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/cid\/cir857","volume":"54","author":"BW Wieland","year":"2012","unstructured":"Wieland BW, Marcantoni JR, Bommarito KM, Warren DK, Marschall J. A retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections Due to Methicillin\u2013Susceptible Staphylococcus aureus. Clin Infect Dis. 2012;54:585\u201390.","journal-title":"Clin Infect Dis."},{"key":"359_CR39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/cid\/cit188","volume":"57","author":"HM Nguyen","year":"2013","unstructured":"Nguyen HM, Jones RN. Susceptible staphylococcus prosthetic joint infections: using the oxacillin minimum inhibitory concentration to guide appropriate. Clin Infect Dis. 2013;57:161\u20132.","journal-title":"Clin Infect Dis."},{"key":"359_CR40","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis and management of prosthetic joint infection : clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis. 2013;56:e1\u201325.","journal-title":"Clin Infect Dis."},{"key":"359_CR41","unstructured":"Ambrose PG. Ceftriaxone: reappraisal of Federal Drug Administration in vitro susceptibility testing interpretive criteria: Institute for Clinical Pharmacodynamics 2011. http:\/\/www.clsi.org\/wp-content\/uploads\/2011\/12\/6_MicroAST_PK_PDCeftriaxone_Jan2011.pdf."},{"key":"359_CR42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1128\/AAC.48.1.53-62.2004","volume":"48","author":"HS Sader","year":"2004","unstructured":"Sader HS, Johnson DM, Jones RN. In Vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci. Antimicrob Agents Chemother. 2004;48:53\u201362.","journal-title":"Antimicrob Agents Chemother."},{"key":"359_CR43","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9343(03)00231-6","volume":"114","author":"AD Tice","year":"2003","unstructured":"Tice AD, Hoaglund PA, Shoultz DA. Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Am J Med. 2003;114:723\u20138.","journal-title":"Am J Med."},{"key":"359_CR44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/313620","volume":"30","author":"BJ Guglielmo","year":"2000","unstructured":"Guglielmo BJ, Luber AD, Paletta DJ, Jacobs RA. Ceftriaxone therapy for staphylococcal osteomyelitis: a review. Clin Infect Dis. 2000;30:205\u20137.","journal-title":"Clin Infect Dis."},{"key":"359_CR45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1542\/peds.55.2.213","volume":"55","author":"RD Feigin","year":"1975","unstructured":"Feigin RD, Pickering LK, Anderson D, Keeney RE, Shackleford PG. Clindamycin treatment of osteomyelitis and septic arthritis in children. Pediatr. 1975;55:213\u201323.","journal-title":"Pediatr."},{"key":"359_CR46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/BPO.0b013e31817bb816","volume":"28","author":"J Saavedra-Lozano","year":"2008","unstructured":"Saavedra-Lozano J, Mejias A, Ahmad N, Peromingo E, Ardura MI, et al. Changing trends in acute osteomyelitis in children: impact of methicillin-resistant Staphylococcus aureus infections. J Pediatr Orthop. 2008;28:569\u201375.","journal-title":"J Pediatr Orthop."},{"key":"359_CR47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","volume":"82","author":"F-Y Chang","year":"2003","unstructured":"Chang F-Y, Peacock JEJ, Musher DM, Triplett P, MacDonald BB, Mylotte JM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Med (Baltim). 2003;82:333\u20139.","journal-title":"Med (Baltim)."},{"key":"359_CR48","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18\u201355.","journal-title":"Clin Infect Dis."},{"key":"359_CR49","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jinf.2007.07.012","volume":"55","author":"PC Matthews","year":"2007","unstructured":"Matthews PC, Taylor A, Byren I, Atkins BL. Teicoplanin levels in bone and joint infections: are standard doses subtherapeutic? J Infect. 2007;55:408\u201313.","journal-title":"J Infect."},{"key":"359_CR50","first-page":"3669","volume":"4","author":"GM Pacifici","year":"2016","unstructured":"Pacifici GM. Clinical pharmacology of teicoplanin in neonates: effects and pharmacokinetics. Int J Pediatr. 2016;4:3669\u201384.","journal-title":"Int J Pediatr."},{"key":"359_CR51","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00006454-199606000-00005","volume":"15","author":"G Dufort","year":"1996","unstructured":"Dufort G, Ventura C, Olive T, Ortega JJ. Teicoplanin pharmacokinetics in pediatric patients. Pediatr Infect Dis J. 1996;15:494\u20138.","journal-title":"Pediatr Infect Dis J."},{"key":"359_CR52","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/0003088-200847120-00004","volume":"47","author":"S Garazzino","year":"2008","unstructured":"Garazzino S, Aprato A, Baietto L, D'Avolio A, Maiello A, De Rosa FG, et al. Glycopeptide bone penetration in patients with septic pseudoarthrosis of the Tibia. Clin Pharmacokinet. 2008;47:793\u2013805.","journal-title":"Clin Pharmacokinet."},{"key":"359_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16193557","author":"E Chiappini","year":"2019","unstructured":"Chiappini E, Serrano E, Galli L, Villani A, Krzysztofiak A. Practical issues in early switching from intravenous to oral antibiotic therapy in children with uncomplicated acute hematogenous osteomyelitis: results from an italian survey. Int J Environ Res Public Health. 2019. https:\/\/doi.org\/10.3390\/ijerph16193557.","journal-title":"Int J Environ Res Public Health."},{"key":"359_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2019.07.016","author":"C Brehin","year":"2019","unstructured":"Brehin C, Claudet I, Dubois D, Sales de Gauzy J, Vial J, Chaix Y, et al. Assessing the management of pediatric bone and joint infections according to French guidelines. Med Mal Infect. 2019. https:\/\/doi.org\/10.1016\/j.medmal.2019.07.016.","journal-title":"Med Mal Infect."},{"key":"359_CR55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.31486\/toj.18.0138","volume":"19","author":"N Thakolkaran","year":"2019","unstructured":"Thakolkaran N, Shetty AK. Acute hematogenous osteomyelitis in children. Ochsner J. 2019;19:116\u201322.","journal-title":"Ochsner J."},{"key":"359_CR56","first-page":"519","volume":"3","author":"J Schuppen","year":"2012","unstructured":"Schuppen J, van Doorn M, Rijn R. Childhood osteomyelitis: imaging characteristics. Insights. Imaging. 2012;3:519\u201333.","journal-title":"Imaging."},{"key":"359_CR57","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5409\/wjcp.v5.i3.244","volume":"5","author":"N Batchelder","year":"2016","unstructured":"Batchelder N, So T-Y. Transitioning antimicrobials from intravenous to oral in pediatric acute uncomplicated osteomyelitis. World J Clin Pediatr. 2016;5:244\u201350.","journal-title":"World J Clin Pediatr."},{"key":"359_CR58","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/INF.0b013e31812e62dc","volume":"26","author":"C-J Chen","year":"2007","unstructured":"Chen C-J, Chiu C-H, Lin T-Y, Lee Z-L, Yang W-E, Huang Y-C. Experience with linezolid therapy in children with osteoarticular infections. Pediatr Infect Dis J. 2007;26:985\u20138.","journal-title":"Pediatr Infect Dis J."},{"key":"359_CR59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clinthera.2010.01.019","volume":"32","author":"E Chiappini","year":"2010","unstructured":"Chiappini E, Conti C, Galli L, de Martino M. Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review. Clin Ther. 2010;32:66\u201388.","journal-title":"Clin Ther."},{"key":"359_CR60","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1345\/aph.1D156","volume":"38","author":"M Adra","year":"2004","unstructured":"Adra M, Lawrence KR. Trimethoprim\/sulfamethoxazole for treatment of severe Staphylococcus aureus infections. Ann Pharmacother. 2004;38:338\u201341.","journal-title":"Ann Pharmacother."},{"key":"359_CR61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/dkt374","volume":"69","author":"BN Kim","year":"2014","unstructured":"Kim BN, Kim ES, Oh MD. Oral antibiotic treatment of Staphylococcal bone and joint infections in adults. J Antimicrob Chemother. 2014;69:309\u201322.","journal-title":"J Antimicrob Chemother."},{"key":"359_CR62","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jac\/22.6.873","volume":"22","author":"V Yeldandi","year":"1988","unstructured":"Yeldandi V, Strodtman R, Lentino JR. In-vitro and in-vivo studies of trimethoprim\u2013sulphamethoxazole against multiple resistant Staphylococcus aureus. J Antimicrob Chemother. 1988;22:873\u201380.","journal-title":"J Antimicrob Chemother"},{"key":"359_CR63","first-page":"385","volume":"30","author":"MC Saux","year":"1982","unstructured":"Saux MC, Le Rebeller A, Leng B, Mintrosse J. Bone diffusion of trimethoprim and sulfamethoxazole high pressure liquid chromatography (HPLC) (author\u2019s transl). Pathol Biol (Paris). 1982;30:385\u20138.","journal-title":"Pathol Biol (Paris)."},{"key":"359_CR64","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1128\/AAC.42.12.3086","volume":"42","author":"A Stein","year":"1998","unstructured":"Stein A, Bataille JF, Drancourt M, Curvale G, Argenson JN, Groulier P, et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother. 1998;42:3086\u201391.","journal-title":"Antimicrob Agents Chemother."},{"key":"359_CR65","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1093\/jac\/dkx153","volume":"72","author":"N Eliakim-Raz","year":"2017","unstructured":"Eliakim-Raz N, Hellerman M, Yahav D, Cohen J, Margalit I, Fisher S, et al. Trimethoprim\/sulfamethoxazole versus vancomycin in the treatment of healthcare\/ventilator-associated MRSA pneumonia: a case-control study. J Antimicrob Chemother. 2017;72:2687.","journal-title":"J Antimicrob Chemother."},{"key":"359_CR66","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ijantimicag.2017.12.011","volume":"51","author":"MA Pfaller","year":"2018","unstructured":"Pfaller MA, Flamm RK, Castanheira M, Sader HS, Mendes RE. Dalbavancin in-vitro activity obtained against gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011\u20132016). Int J Antimicrob Agents. 2018;51:608\u201311.","journal-title":"Int J Antimicrob Agents."},{"key":"359_CR67","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1310480","volume":"370","author":"HW Boucher","year":"2014","unstructured":"Boucher HW, Wilcox M, Talbot GH, Puttagunta S, Das AF, Dunne MW. Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med. 2014;370:2169\u201379.","journal-title":"N Engl J Med."},{"key":"359_CR68","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ijantimicag.2016.04.009","volume":"47","author":"MD Huband","year":"2016","unstructured":"Huband MD, Castanheira M, Farrell DJ, Flamm RK, Jones RN, Sader HS, et al. In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011\u20132013). Int J Antimicrob Agents. 2016;47:495\u20139.","journal-title":"Int J Antimicrob Agents."},{"key":"359_CR69","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s40262-015-0281-3","volume":"54","author":"TKL Kiang","year":"2015","unstructured":"Kiang TKL, Wilby KJ, Ensom MHH. A critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of ceftaroline. Clin Pharmacokinet. 2015;54:915\u201331.","journal-title":"Clin Pharmacokinet."},{"key":"359_CR70","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/jac\/dkq193","volume":"65","author":"C Jacqueline","year":"2010","unstructured":"Jacqueline C, Amador G, Caillon J, Le Mabecque V, Batard E, Mi\u00e8geville AF, et al. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis. J Antimicrob Chemother. 2010;65:1749\u201352.","journal-title":"J Antimicrob Chemother."},{"key":"359_CR71","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/AAC.02371-13","volume":"58","author":"AM Casapao","year":"2014","unstructured":"Casapao AM, Davis SL, Barr VO, et al. Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy. Antimicrob Agents Chemother. 2014;58:2541\u20136.","journal-title":"Antimicrob Agents Chemother."},{"key":"359_CR72","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","volume":"279","author":"W Zimmerli","year":"1998","unstructured":"Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998;279:1537\u201341.","journal-title":"JAMA"},{"key":"359_CR73","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/infdis\/147.2.352","volume":"147","author":"CW Norden","year":"1983","unstructured":"Norden CW, Shaffer M. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with vancomycin and rifampin. J Infect Dis. 1983;147:352\u20137.","journal-title":"J Infect Dis."},{"key":"359_CR74","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/infdis\/jit129","volume":"208","author":"BA Diep","year":"2013","unstructured":"Diep BA, Afasizheva A, Le HN, Kajikawa O, Matute-Bello G, Tkaczyk C, et al. Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia. J Infect Dis. 2013;208:75\u201382.","journal-title":"J Infect Dis."},{"key":"359_CR75","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1586\/eri.10.34","volume":"8","author":"P Rojo","year":"2010","unstructured":"Rojo P, Barrios M, Palacios A, Gomez C, Chaves F. Community-associated Staphylococcus aureus infections in children. Expert Rev Anti Infect Ther. 2010;8:541\u201354.","journal-title":"Expert Rev Anti Infect Ther."}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-020-00359-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-020-00359-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-020-00359-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T12:37:24Z","timestamp":1666528644000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-020-00359-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1007\/s12519-020-00359-z","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"3 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ethical approval was not needed, since this article was a review article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors do not have any conflict of interest. No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}